Background The evidence on associations between ultra-processed foods (UPF) and lung cancer risk is limited and inconsistent.

In April 2025, Radiopharm dosed the first patient in the U.S. Phase 2b imaging study of 18F-RAD101. The multicenter, open-label, single arm Phase 2b clinical trial is evaluating the diagnostic ...

Media Release The pivotal TACTI-004 Phase III trial in first line non-small cell lung cancer (1L NSCLC) continues to build momentum and is recruiting patients at a growing number of activated clinical ...

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.

Roche Holding AG's H2 2025 earnings show solid growth in pharma revenues but highlight pipeline struggles and U.S. pricing pressures. Click for my RHHBY update.

Frost & Sullivan is pleased to announce that Siemens Healthineers has been awarded the 2025 North America Company of the Year Recognition in the advanced visualization applications industry for its ...

Figure 1 shows the PRISMA flow diagram of the literature selection in this study. Actual screening numbers will be populated during the review process and reported in the final publication. Preset ...